Functional food composition for improving sleep and preparation method thereof

Through functional food composition composed of plant extracts and soluble dietary fiber, the side effects of chemical drugs in treating insomnia are solved, safe and effective improvement of sleep effects, regulate intestinal flora and immune function, and relieve anxiety and depression.

CN120360266APending Publication Date: 2025-07-25SHANGHAI YINUO YIKANG BIOMEDICAL TECH CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202510675656.1
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2025-05-23
Publication Date
2025-07-25

AI Technical Summary

Technical Problem

Existing chemical drugs have side effects, drug resistance and drug dependence in the treatment of insomnia, and dietary therapy methods have not been fully utilized.

Method used

Functional food compositions composed of plant extracts, soluble dietary fiber and a small amount of flavoring agent are prepared into dosage forms such as granules through mixing, granulation and packaging processes to regulate intestinal flora and immune function and improve sleep.

Benefits of technology

It has achieved no side effects and no dependence to improve sleep, significantly regulates intestinal flora and immune function, relieves anxiety and depression, and promotes the release of sleep-related neurotransmitter precursors.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN120360266A_ABST
    Figure CN120360266A_ABST
Patent Text Reader

Abstract

The invention relates to the technical field of food processing, in particular to a functional food composition for improving sleep and a preparation method thereof.The composition is mainly formed by mixing plant extracts with homology of medicine and food, soluble dietary fibers and a small amount of flavoring agent, and the plant extracts account for 30%-70%, the soluble dietary fibers account for 30%-70% and the flavoring agent accounts for 30%-70%. And 0-3% of a flavoring agent. The plant extract comprises 10-40% of a lily water extract; 10-40% of an aqueous extract of Herba Aristolochiae; 5-30% of a rose aqueous extract; and 20-60% of a water extract of daphne odora. The soluble dietary fiber is selected from one or more of pectin, algin, konjak and inulin. The natural and safe functional food is prepared by taking the lily aqueous extract, the carex decora aqueous extract, the rose aqueous extract, the aronia castanea aqueous extract, the algin, the pectin and the like as raw materials through the process steps of mixing, granulating, packaging and the like, and can regulate intestinal flora, regulate immune functions and improve sleep.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the technical field of food processing, and more specifically, to a functional food composition for improving sleep and a preparation method thereof. Background Art

[0002] The decline in sleep quality and the shortening of sleep time seriously affect people's physical and mental health and quality of life, and long-term sleep disorders will also increase the risks of cardiovascular diseases, nervous system diseases, etc. With the development of society and the acceleration of the pace of life, sleep problems are on the rise year by year. At present, the main treatment methods for insomnia patients are psychological counseling and auxiliary chemical drug treatment. However, chemical drug treatment often brings some side effects. For example, dizziness, headache, nausea, loss of appetite, stomachache, etc. will occur in the early stage of taking the drug. In addition, there are memory decline, attention decline, fatigue, decline in quality of life, withdrawal reaction, etc., and long-term use will produce drug resistance and drug dependence.

[0003] Conventional sleep drugs on the market often have side effects and are prone to drug resistance and drug dependence. Diet therapy has a long history of use in China and is easily accepted by people. Therefore, it is urgent to develop functional foods homologous to medicine and food to improve sleep and reduce the dependence or overuse of chemical drugs. Summary of the Invention

[0004] The purpose of the present invention is to solve the deficiencies in the prior art and propose a functional food composition for improving sleep and a preparation method thereof.

[0005] To solve the above problems, the present invention adopts the following technical solutions: A functional food composition for improving sleep, the functional food composition includes the following components: plant extract, soluble dietary fiber and a small amount of flavoring agent.

[0006] Preferably, the functional food composition is composed of 30 - 70% of plant extract, 30 - 70% of soluble dietary fiber, and 0 - 3% of flavoring agent by mass percentage.

[0007] Furthermore, the plant extract is composed of 10 - 40% of lily aqueous extract; 10 - 40% of jieyoucao aqueous extract, 5 - 30% of rose aqueous extract and 20 - 60% of bulao plum aqueous extract by mass percentage.

[0008] Furthermore, the soluble dietary fiber is selected from one or more of pectin, alginate, konjac, inulin, and can be mixed in any proportion.

[0009] Furthermore, the functional food composition is one or more of granules, decoctions, oral liquids, dripping pills, tablets, capsules, functional beverages, prepared soft drinks, solid drinks, jellies or pastries, etc.

[0010] Furthermore, the dosage form of the functional food composition is granules.

[0011] The present invention also provides a preparation method of a functional food composition for improving sleep, and the preparation method includes the following steps: 1) Mix the plant extracts: lily water extract, jieyoucao water extract, rose water extract, and bulao plum water extract in a certain proportion; 2) Place the mixture of each plant extract, soluble dietary fiber, and a small amount of flavoring agent in a wet granulator according to the mass percentage; 3) Spray 75% ethanol into the wet granulator, adjust the stirring speed, and complete granulation; 4) Dry the wet granules at 60 ± 5 °C until the water content is not more than 5% to obtain dry granules; 5) Pass the dry granules through a No. 2 sieve (24 meshes) and a No. 4 sieve (65 meshes), and collect the granules between the two; 6) Seal and package with an aluminum-plastic composite film.

[0012] Furthermore, the functional food composition can be used to condition or improve sleep disorders, sleep dysregulation disorders, depression, and anxiety disorders.

[0013] Compared with the prior art, the advantages of the present invention are as follows: The present invention uses lily water extract, jieyoucao water extract, rose water extract, bulao plum water extract, alginate, pectin, etc. as raw materials, and through process steps such as mixing, granulation, and packaging, a natural and safe functional food is prepared to improve sleep.

[0014] The plant extracts used in the present invention can effectively regulate the intestinal flora, regulate the body's immunity, promote the release of sleep-related neurotransmitter precursors, stimulate the body's self-regulatory ability, and regulate the circadian rhythm, thereby helping to improve sleep, relieve stress, reduce anxiety and depressive emotions.

[0015] The present invention is composed of plant extracts and is safe, non-toxic, and has no side effects.

[0016] The present invention has a simple formula, low cost, and remarkable effects. Description of the Drawings

[0017] Figure 1 For products C and D to reduce the proportion of activated monocytes (MHCII+ monocytes); Figure 2Reduce the proportion of activated CD8+ T cells (CD25+CD8+ T) for products C and D; Figure 3 Experimental method for increasing the proportion of Treg cells in the culture system for products C and D; Figure 4 Cumulative chart of the spontaneous activity of mice 6 h after the first administration of product D; Figure 5 Cumulative chart of the spontaneous activity of mice 6 h after cage changing during 5 consecutive days of drug administration; Figure 6 Effect of product D on the sleep duration of A53T transgenic mice.

[0018] The accompanying drawings are used to provide a further understanding of the present invention and constitute a part of the specification. Together with the embodiments of the present invention, they are used to explain the present invention and do not constitute a limitation to the present invention. Detailed implementation manners

[0019] The technical solutions in the embodiments of the present invention will be clearly and completely described below with reference to the accompanying drawings in the embodiments of the present invention. Obviously, the described embodiments are only a part of the embodiments of the present invention, rather than all of the embodiments. All other embodiments obtained by those of ordinary skill in the art based on the embodiments of the present invention without creative efforts shall fall within the scope of protection of the present invention.

[0020] Unless otherwise defined, all professional and scientific terms used herein have the same meaning as those familiar to those skilled in the art. In addition, any methods and materials similar or equivalent to the described content can be applied to the present invention. The preferred implementation methods and materials described herein are only for illustrative purposes and do not limit the content of this application.

[0021] The experimental methods in the following embodiments are all conventional methods unless otherwise specified; the test materials and test strains used in the following embodiments are all obtained from commercial channels unless otherwise specified.

[0022] Example 1 A functional food composition for improving sleep and its preparation method: Weigh 50 g of the water extract of Aged Plum, 50 g of the water extract of Lily, 50 g of the water extract of Worry-Relieving Grass, and 40 g of the water extract of Rose, mix them evenly, and place them in a wet granulator. Then weigh 80 g of alginate, 20 g of pectin, and 10 g of stevioside, place them in the wet granulator, start stirring at 60 revolutions per minute, chopping at 2000 revolutions per minute, mix for 5 minutes, slowly spray in 75% ethanol, adjust the stirring speed to 80 revolutions per minute, and the chopping speed to 2000 revolutions per minute. Observe the granulation effect. When wet granules are clearly visible, confirm it as the granulation end point, start sizing (600 revolutions per minute) and discharging. Dry the wet granules in a hot air circulation oven at 60 °C until the water content reaches 5% to obtain dry granules. Screen the dry granules and collect the granules between the No. 2 sieve (24 mesh) and the No. 4 sieve (65 mesh). Mix in a mixer at 10 revolutions per minute for 10 minutes, package in aluminum-plastic composite film bags, 3 g per bag, and seal to obtain Product A.

[0023] Example 2 A functional food composition for improving sleep and its preparation method: Weigh 50 g of the water extract of Aged Plum, 50 g of the water extract of Lily, 40 g of the water extract of Worry-Relieving Grass, and 50 g of the water extract of Rose, mix them evenly, and place all of them in a wet granulator. Then weigh 90 g of alginate, 10 g of pectin, and 10 g of stevioside, place them in the wet granulator, start stirring at 60 revolutions per minute, chopping at 2000 revolutions per minute, mix for 5 minutes, slowly spray in 75% ethanol, adjust the stirring speed to 80 revolutions per minute, and the chopping speed to 2000 revolutions per minute. Observe the granulation effect. When wet granules are clearly visible, confirm it as the granulation end point, start sizing (600 revolutions per minute) and discharging. Dry the wet granules in a hot air circulation oven at 60 °C until the water content reaches 5% to obtain dry granules. Screen the dry granules and collect the granules between the No. 2 sieve (24 mesh) and the No. 4 sieve (65 mesh). Mix in a mixer at 10 revolutions per minute for 10 minutes, package in aluminum-plastic composite film bags, 4 g per bag, and seal to obtain Product B.

[0024] Example 3 A functional food composition for improving sleep and its preparation method: Weigh 45 g of the water extract of Aged Plum, 20 g of the water extract of Lily, 20 g of the water extract of Jieyoucao, and 10 g of the water extract of Rose, mix them evenly. Put all the mixture into a wet granulator. Then weigh 90 g of alginate, 10 g of pectin, and 10 g of stevioside, put them into the wet granulator. Start stirring at 60 revolutions per minute, chopping at 2000 revolutions per minute, and mix for 5 minutes. Slowly spray in 75% ethanol, adjust the stirring speed to 80 revolutions per minute, and keep chopping at 2000 revolutions per minute. Observe the granulation effect. When wet granules are significantly formed, confirm it as the granulation end point. Start sizing (at 600 revolutions per minute) and discharging. Dry the wet granules in a hot air circulation oven at 60 °C until the water content reaches 5% to obtain dry granules. Screen the dry granules and collect the granules between the second sieve (24 meshes) and the fourth sieve (65 meshes). Mix in a mixer at 10 revolutions per minute for 10 minutes, pack in aluminum-plastic composite film bags, 4 g per bag, and seal to obtain Product C.

[0025] Example 4 A functional food composition for improving sleep and its preparation method: Weigh 90 g of the water extract of Aged Plum, 40 g of the water extract of Lily, 40 g of the water extract of Jieyoucao, and 20 g of the water extract of Rose, mix them evenly. Put all the mixture into a wet granulator. Then weigh 90 g of alginate, 10 g of pectin, and 10 g of stevioside, put them into the wet granulator. Start stirring at 60 revolutions per minute, chopping at 2000 revolutions per minute, and mix for 5 minutes. Slowly spray in 75% ethanol, adjust the stirring speed to 80 revolutions per minute, and keep chopping at 2000 revolutions per minute. Observe the granulation effect. When wet granules are significantly formed, confirm it as the granulation end point. Start sizing (at 600 revolutions per minute) and discharging. Dry the wet granules in a hot air circulation oven at 60 °C until the water content reaches 5% to obtain dry granules. Screen the dry granules and collect the granules between the second sieve (24 meshes) and the fourth sieve (65 meshes). Mix in a mixer at 10 revolutions per minute for 10 minutes, pack in aluminum-plastic composite film bags, 4 g per bag, and seal to obtain Product D.

[0026] Experimental Example 1 In vitro experiment 1. In vitro experiment materials Fecal samples of people with sleep disorders, C57BL / 6 mice 1.1 Drugs and reagents Select Product C and Product D for in vitro detection; flora culture medium, anti-mouse CD4 antibody, anti-mouse FOXP3 antibody, anti-mouse CD8 antibody, anti-mouse CD5 antibody, anti-mouse CD11b antibody, anti-mouse Ly6C antibody.

[0027] 1.2 Instruments Anaerobic workstation, model H35 HEPA, Huayuexing Instrument Co., Ltd.; Vertical autoclave, model: SQ810C, Chongqing Yamato Technology Co., Ltd.; Refrigerated high-speed centrifuge, model 5810R, Eppendorf; Electronic balance, model 481, Sartorius; Cell imaging microplate detection system, model Cytation 5, BioTek; Cryogenic storage box, model 907, Thermo Fisher; Centrifuge, model 5427R, Eppendorf; Cell counter, model IC1000, Countstar; Flow cytometer, model Fortessa X-20, BD.

[0028] 2. Experimental methods Microbiota culture: Experimental consumables and reagents were placed in the anaerobic workstation overnight; Fecal samples from sleep disorder patients were transferred to centrifuge tubes and prepared into suspensions with microbiota medium. After filtration, the suspensions were transferred to 96-well deep-well plates at 1 mL / well, placed on a shaker, shaken at low speed, and centrifuged to collect the microbiota supernatant after 24 h of culture.

[0029] Immune cell culture and detection: C57BL / 6 mice were taken, and spleens were taken under sterile conditions and ground into single-cell suspensions. The obtained lymphocytes were counted and inoculated into 48-well plates. Fecal microbiota supernatant medium and corresponding compounds were added, and after 24 h of culture, the cells were collected for flow cytometry detection. The obtained detection data were processed with flowjo software to obtain the proportions of various immune cells.

[0030] 3. Experimental results Sleep disorders can activate inflammatory signaling pathways, which include the signaling pathways of NF-κB and STAT family proteins. By increasing the levels of mRNAs encoding pro-inflammatory cytokines, the activation of immune cells is enhanced, promoting the production of inflammatory factors such as IL-6 and TNF. The continuous activation of the inflammatory response mediated by persistent sleep disorders can cause damage to the host. There is a bidirectional regulation between sleep quality and the composition of the gut microbiota, and the disorder of the gut microbiota is involved in multiple physiological processes such as sleep disorders and immune regulation. Therefore, by collecting fecal samples from people with sleep disorders and using means and techniques such as in vitro culture and immunoassay, the effects of products C and D on inflammatory-related immune cells stimulated by the gut microbiota culture supernatant were investigated. The results showed that the microbiota culture supernatant could significantly increase the activation of monocytes (Figure 1), increase the activation of CD8+ T cells (Figure 2), and decrease the proportion of immune-inflammatory inhibitory cells Tregs (Figure 3), indicating that people with sleep disorders can promote the body's inflammatory response by acting on the above immune cells. After adding 5 mg / ml X to intervene in the microbiota, its culture supernatant could dose-dependently reverse the above inflammatory changes, manifested as reducing the activation of monocytes, inhibiting the activation of CD8+ T cells, and increasing the proportion of Treg cells. Among them, for the activation of monocytes and CD8+ T cells, the inhibitory effect of product D was the most obvious. The above results indicate that product D can play an immune-inflammatory regulatory role by acting on the gut microbiota of people with sleep disorders and reduce the body's inflammatory response.

[0031] Experimental Example 2 In vivo experiment 1. Materials for in vivo experiment Based on the in vitro experimental results, product D was selected for further in vivo animal experiments, with three doses of high, medium, and low, which were 25 mg / kg, 50 mg / kg, and 100 mg / kg, respectively.

[0032] SPF-grade male C57BL / 6J mice (22 - 26 g, 11 - 13 weeks old), A53T (α-synuclein transgenic line M83) mice (Tg mice), and all experimental operations followed the ethical guidelines of the animal use system.

[0033] 1.1 Drugs and reagents Diazepam 1.2 Instruments infrared assays instrument (Biotex, Kyoto, Japan) 2. Experimental methods 1) Determination of locomotor activity SPF-grade male C57BL / 6J mice were housed in an environment with a room temperature of 22 ± 0.5 ºC, a relative humidity of 60 ± 2%, and an automatic light control of 12 h light period / 12 h dark period (light on time: 07:00, light intensity ≈ 100 lux). Animals had free access to food and water. The drug was administered once a day for five consecutive days, and the administration was completed within 15 minutes before turning off the lights. The results on the first day of administration were the acute effects, and the results on the fifth day were the effects after continuous drug use.

[0034] Four mice were housed in each cage for 5 days, and then the mice were placed individually in recording cages. After 2 days of adaptation, the spontaneous activity was recorded. For 5 consecutive days, intragastric administration (negative, positive, and three doses of the test drug) was performed at 18:45 - 19:00 (before turning off the lights). The administration volume was 20 ml / kg. The spontaneous activity was continuously recorded for 5 days during drug administration and 48 h after drug withdrawal. After drug administration on the fifth day, the mice were moved to clean cages (MCC). The spontaneous activity during and after drug administration was statistically analyzed. After each animal experiment, the animals were no longer used.

[0035] Spontaneous activity was detected using an infrared assays instrument (Biotex, Kyoto, Japan). Requirements for the recording box environment: constant temperature, constant humidity, sound insulation, and a 12 h / 12 h light-dark cycle. The mice were individually placed in a 28×16.5 cm transparent cage, with a distance of 14 cm between adjacent cages. The infrared camera was fixed directly above the cage, 17.5 cm from the bottom of the cage. According to the experimental purpose, 5 minutes was selected as the sampling interval point, and the spontaneous activity of the animals was collected and recorded. The results were expressed as the cumulative spontaneous activity in 1 h. Animal grouping and treatment are shown in Table 1: Table 1 Animal grouping and treatment Table 1 Animal grouping and treatment 2) Non-invasive sleep test A53T (α-synuclein transgenic line M83) mice (Tg mice) were used and housed in an SPF-grade room in IVC cages, with no more than 5 mice per cage. Animals had free access to filtered water and autoclaved mouse food. The cage bedding was autoclaved bedding and was changed once a week. The temperature in the animal housing room was maintained between 19 - 26 °C (66 - 79 °F), and the relative humidity was 40 - 70%. The temperature and humidity were continuously observed and recorded. The lighting condition was 12 hours (06:00 - 18:00) of fluorescent lamp irradiation and 12 hours of no lighting per day.

[0036] After grouping the A53T mice, the Tg + treatment group was given corresponding treatment by gavage according to body weight, once a day, continuously until the end of the experiment. The Tg group was given an appropriate amount of normal saline. Non-invasive sleep tests were performed after 1 month.

[0037] Before the sleep test of the mice, they were transferred to the test environment and allowed to adapt for 30 minutes. The PiezoSleep non-invasive sleep detection system was used to measure the sleep duration of the mice within 24 hours. The mice were allowed to eat and drink freely during the test.

[0038] 3. Experimental Results The cumulative amount of spontaneous activity of C57BL / 6J mice 6 hours after the first administration was counted. The results of one-way ANOVA indicated that there were significant differences in the cumulative amount of spontaneous activity at 6 h among the 5 groups (F (4,53)=7.01, P<0.001). Further pairwise comparisons using the PLSD method showed that compared with the negative control group, the high-dose group of Product D (100 mg / kg) and the positive control drug diazepam group could significantly reduce the total amount of spontaneous activity, and there was no significant difference between the two groups (P>0.05). There was no significant difference between the low- and medium-dose groups of Product D and the negative control group (Figure 4).

[0039] The experimental animals were administered once a day for five consecutive days, and the changes in the total amount of spontaneous activity of the 5 groups of mice 6 h after continuous administration for 5 days before and after administration were observed. After administration on the fifth day, the cages were changed, and the effect of the drug on the total amount of spontaneous activity of the animals in the new environment was observed. The results showed that the medium- and high-dose groups of Product D could significantly reduce the spontaneous activity of the animals, and the effect was comparable to that of the positive control group ( Figure 5 )

[0040] A non-invasive sleep monitoring experiment was conducted using A53T transgenic mice. The total sleep duration of these transgenic mice significantly decreased after onset. After grouping the A53T mice, the experimental animals were administered once a day. The Tg + treatment group was given corresponding treatment by gavage according to body weight; the Tg group was given an appropriate amount of normal saline, and non-invasive sleep tests were continuously performed for 30 days. Before the sleep test of the mice, they were transferred to the test environment and allowed to adapt for 30 minutes. The PiezoSleep non-invasive sleep detection system was used to measure the sleep duration of the mice within 24 hours. The mice were allowed to eat and drink freely during the test. The results showed that continuous administration of Product D for 30 days could significantly increase the total sleep time of the animals (Figure 6).

[0041] Although the embodiments of the present invention have been shown and described, it will be understood by those of ordinary skill in the art that various changes, modifications, substitutions, and variations can be made to these embodiments without departing from the principles and spirit of the present invention. The scope of the present invention is defined by the appended claims and their equivalents.

[0042] The above describes the present invention and its implementation manners. Such description is not restrictive. What is shown in the drawings is only one of the implementation manners of the present invention, and the actual structure is not limited thereto. In general, if those of ordinary skill in the art are inspired by it and, without departing from the gist of the present invention, design similar structural manners and embodiments to this technical solution without creative efforts, they shall fall within the protection scope of the present invention.

Claims

1. A functional food composition for improving sleep, characterized in that: The functional food composition comprises the following components: plant extract, soluble dietary fiber and flavoring agent.

2. The functional food composition for improving sleep according to claim 1, characterized in that: The functional food composition is prepared by mixing 30 - 70% of plant extract, 30 - 70% of soluble dietary fiber and 0 - 3% of flavoring agent by mass percentage.

3. The functional food composition for improving sleep according to claim 2, wherein: The plant extract is prepared by mixing 10 - 40% of lily aqueous extract, 10 - 40% of jieyoucao aqueous extract, 5 - 30% of rose flower aqueous extract and 20 - 60% of bulao plum aqueous extract by mass percentage.

4. The functional food composition for improving sleep according to claim 1, wherein: The soluble dietary fiber is selected from one or more of pectin, alginate, konjac, inulin.

5. The functional food composition for improving sleep according to claim 4, wherein: The functional food composition is one or more of granule, decoction, oral liquid, dripping pill, tablet, capsule, functional beverage, soft drink, solid drink, jelly or pastry.

6. The functional food composition for improving sleep according to claim 5, wherein: The dosage form of the functional food composition is granule.

7. The preparation method of a functional food composition for improving sleep according to any one of claims 1-6, characterized in that: It includes the following steps: 1) Mix the plant extracts: lily aqueous extract, jieyoucao aqueous extract, rose flower aqueous extract, bulao plum aqueous extract in proportion; 2) Place the mixture of each plant extract, soluble dietary fiber and a small amount of flavoring agent in a wet granulator according to the mass percentage; 3) Spray 75% ethanol into the wet granulator, adjust the stirring speed to complete granulation; 4) Place the wet granules in an oven at 60 ± 5 °C and dry until the water content is not more than 5% to obtain dry granules; 5) Pass the dry granules through a 24 - mesh No. 2 sieve and a 65 - mesh No. 4 sieve, and collect the granules between the two; 6) Seal and package with an aluminum - plastic composite film.